(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced the U.S. Food and Drug Administration approval of BRAVECTO QUANTUM (fluralaner for extended-release injectable ...
Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...
The U.S. Food and Drug Administration has approved a new shot that protects dogs six months or older against fleas and ticks. Merck Animal Health's Bravecto Quantum is officially the first FDA ...
12-Month Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products BRAVECTO QUANTUM was first approved in Australia and New Zealand in 2023, ...
A new option, BRAVECTO (R) QUANTUM is the first and only parasiticide that protects dogs against fleas and ticks for an entire year in just one dose.* It's administered by a vet once yearly, meaning ...
Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...
The MarketWatch News Department was not involved in the creation of this content. KIRKLAND, QC, Oct. 2, 2025 /CNW/ -- Merck Animal Health, known as MSD Animal Health outside of the United States and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results